DICE Therapeutics, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q2 2022 to Q3 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
DICE Therapeutics, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q2 2022 to Q3 2022.
- DICE Therapeutics, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending August 31, 2022 was $1.5M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)